Evidence map›Paper›PMID 34442459›Full record

ArticleJournal of personalized medicine2021

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington Association.

Filipa Júlio, Ruth Blanco, Josè Perez Casanova, Barbara D'Alessio, Beatrice De Schepper, Dina De Sousa, Paul De Sousa, Cristina Ferreira, Hans Gommans, Rob Haselberg and 12 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Filipa JúlioEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.ORCID 0000-0001-6075-6887
Ruth BlancoEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Josè Perez CasanovaEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Barbara D'AlessioEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Beatrice De SchepperEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Dina De SousaEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Paul De SousaEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Cristina FerreiraEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Hans GommansEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.ORCID 0000-0003-3948-8106
Rob HaselbergEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.ORCID 0000-0003-1892-1724
Emilie HermantEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Danuta LisEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Sabrina MaffiHuntington and Rare Diseases Unit, IRCCS Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, 71013 Foggia, Italy.
Svein Olaf OlsenEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Marios PapantoniouEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Ferdinando SquitieriHuntington and Rare Diseases Unit, IRCCS Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, 71013 Foggia, Italy.ORCID 0000-0002-7397-1727
Marina TretyakovaEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Zaynab UmakhanovaEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Vladimír VáclavíkEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Michaela WinkelmannEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
Astri ArnesenEuropean Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
On Behalf Of The European Huntington Association

Funding

F. Hoffmann-La Roche EPBA2597097-A46
6 · The paper itself

Abstract

There has been great progress in Huntington's disease (HD) research. Yet, effective treatments to halt disease before the onset of disabling symptoms are still unavailable. Scientific breakthroughs require an active and lasting commitment from families. However, they are traditionally less involved and heard in studies. Accordingly, the European Huntington Association (EHA) surveyed individuals at risk (HDRisk) and with premanifest HD (PreHD) to determine which factors affect their willingness to participate in research. Questions assessed research experience and knowledge, information sources, reasons for involvement and noninvolvement, and factors preventing and facilitating participation. The survey included 525 individuals, of which 68.8% never participated in studies and 38.6% reported limited research knowledge. Furthermore, 52% trusted patient organizations to get research information. Reasons for involvement were altruistic and more important than reasons for noninvolvement, which were related to negative emotions. Obstacles included time/financial constraints and invasive procedures, while professional support was seen as a facilitator. PreHD individuals reported less obstacles to research participation than HDRisk individuals. Overall, a high motivation to participate in research was noted, despite limited experience and literacy. This motivation is influenced by subjective and objective factors and, importantly, by HD status. Patient organizations have a key role in fostering motivation through education and support.

Indexed as

clinical researchclinical trialsHuntington’s diseasepremanifest Huntington’s diseasesurvey

Identifiers

PMID34442459
PMCPMC8400079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.